View More Recent Stories
-
H.C. Wainwright Reiterates Neutral Rating on Kyverna Therapeutics Inc (KYTX)
-
Kyverna Therapeutics (KYTX) Receives U.S. FDA IND Clearance for KYV-101
-
Sell-off in this biopharma stock is 'overdone' says JPMorgan


